Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Assets (2022 - 2025)

Core Laboratories (CLB) has 4 years of Assets data on record, last reported at $591.4 million in Q3 2025.

  • For Q3 2025, Assets fell 1.52% year-over-year to $591.4 million; the TTM value through Sep 2025 reached $591.4 million, down 1.52%, while the annual FY2024 figure was $590.4 million, 0.68% up from the prior year.
  • Assets reached $591.4 million in Q3 2025 per CLB's latest filing, down from $602.1 million in the prior quarter.
  • Across five years, Assets topped out at $602.1 million in Q2 2025 and bottomed at $570.2 million in Q3 2022.
  • Average Assets over 4 years is $590.8 million, with a median of $592.0 million recorded in 2023.
  • Peak YoY movement for Assets: grew 4.21% in 2023, then decreased 1.52% in 2025.
  • A 4-year view of Assets shows it stood at $578.4 million in 2022, then rose by 1.39% to $586.4 million in 2023, then rose by 0.68% to $590.4 million in 2024, then increased by 0.16% to $591.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets were $591.4 million in Q3 2025, $602.1 million in Q2 2025, and $591.5 million in Q1 2025.